SEARCH

SEARCH BY CITATION

References

  • 1
    Peters BS, Matthews J, Gompels M, Hartley JC, Pinching AJ. Acute myeloblastic leukemia in AIDS. AIDS 1990; 4:3678.
  • 2
    Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002; 2:93344.
  • 3
    Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:113341.
  • 4
    Hashimoto T, Akiyama K, Kobayashi N, Mori A. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int Arch Allergy Immunol 2005; 137 (Suppl. 1):514.
  • 5
    Maini RN, Taylor PC, Szechinski J et al. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum 2006; 54:281729.
  • 6
    Chen X, Vodanovic-Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski WR. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007; 110:380413.
  • 7
    Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:2358.
  • 8
    Mangan PR, Harrington LE, O'Quinn DB et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441:2314.
  • 9
    Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TG F-beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:17989.
  • 10
    Ivanov II, McKenzie BS, Zhou L et al. The orphan nuclear receptor ROR gamma t directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126:112133.
  • 11
    McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008; 28:44553.
  • 12
    Volpe E, Servant N, Zollinger R et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008; 9:6507.
  • 13
    Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8:9429.
  • 14
    Pages F, Berger A, Camus M et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353:265466.
  • 15
    Peng SL, Townsend MJ, Hecht JL, White IA, Glimcher LH. T-bet regulates metastasis rate in a murine model of primary prostate cancer. Cancer Res 2004; 64:4525.
  • 16
    Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005; 65:245764.
  • 17
    Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM. Intratumoral CD4+CD25+ regulatory T cell-mediated suppression of infiltrating CD4+T cells in B cell non-Hodgkin lymphoma. Blood 2006; 107:363946.
  • 18
    Wang X, Zheng J, Liu J et al. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients. Eur J Haematol 2005; 75:46876.
  • 19
    Kryczek I, Wei S, Zou L et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 2007; 178:67303.
  • 20
    Zhang B, Rong G, Wei H et al. The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 2008; 374:5337.
  • 21
    Tallman MS, Gary Gilliland D, Rowe JM. Drug therapy for acute myeloid leukemia. Blood 2005; 106:115463.
  • 22
    Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the acute leukaemias. French–American–British (FAB) Co-operative Group. Br J Haematol 1976; 33:4518.
  • 23
    Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French–American–British Cooperative Group. Ann Intern Med 1985; 103:6205.
  • 24
    Cheson BD, Cassileth PA, Head DR et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8:81319.
  • 25
    Petersen CM, Christensen EI, Andresen BS, Moller BK. Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells. Exp Cell Res 1992; 201:16073.
  • 26
    Mollers M, Aries SP, Dromann D, Mascher B, Braun J, Dalhoff K. Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax 2001; 56:48793.
  • 27
    Fass MM, Bouman A, Veenstra van Nieuwenhoven AL et al. Species differences in the effect of pregnancy on lymphocyte cytokine production between human and rat. J Leukoc Biol 2005; 78:94653.
  • 28
    Wrobel T, Mazur G, Jazwiec B, Kuliczkowski K. Interleukin-17 in acute myeloid leukemia. J Cell Mol Med 2003; 7:4724.
  • 29
    Numasaki M, Fukushi J, Ono M et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003; 101:26207.
  • 30
    Numasaki M, Watanabe M, Suzuki T et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005; 175:617789.
  • 31
    Muranski P, Boni A, Antony PA et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 2008; 112:36273.
  • 32
    Scarisbrick JJ, Whittaker S, Evans AV et al. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 2001; 97:62430.
  • 33
    Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin17-producing helper T cells. Nat Immunol 2007; 8:9507.
  • 34
    Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007; 56:293646.
  • 35
    Yang L, Anderson DE, Baecher-Allan C et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008; 454:3502.
  • 36
    Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9:6419.